Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-027781

President and CEO sold 16,149 shares at $5.02 ($81,068)

  • President and CEO acquired 16,149 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Doerfler Douglas · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-03 Exercise or conversion : show line 1 in the form 10b5-1 +16,149 $0.04 $646 349,346 D
2023-05-03 Sale : show line 2 in the form 10b5-1 −16,149 $5.02 $81,068 333,197 D
Open-market sales · 16,149 sh · avg $5.02 · $81,068

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-03 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (right to buy) −16,149 308,931 D
Loading xslF345X04/doc4.xml…